Clinical Trial Update: Safety and Efficacy of Canagliflozin in Advanced CKD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the safety and efficacy of canagliflozin in advanced chronic kidney disease, including end-stage renal disease and CKD …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Chronic Kidney Disease Stage
• End-stage Renal Disease

Drugs mentioned

• Invokana (canagliflozin) (canagliflozin)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: ESRD, CKD Stage 4 | Phase 4 | Status: ACTIVE_NOT_RECRUITING